Accepted for Publication: March 10, 2022.
Published: April 27, 2022. doi:10.1001/jamanetworkopen.2022.9199
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Guo L et al. JAMA Network Open.
Corresponding Authors: Jianwei Wang, PhD, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 9 Dong Dan San Tiao, Dongcheng District, Beijing 100730, PR China (email@example.com); Bin Cao, MD, Center for Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China, No. 2, East Yinghua Rd, Chaoyang District, Beijing 100029, PR China (firstname.lastname@example.org).
Author Contributions: Drs Wang and Cao had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Guo and Zhang contributed equally to this work as co-first authors. Drs Cao and Wang contributed equally to this work as co-senior authors.
Concept and design: Guo, Q. Zhang, Ren, Cao, Wang.
Acquisition, analysis, or interpretation of data: Guo, Q. Zhang, C. Zhang, Huang, Wang.
Drafting of the manuscript: Guo, Q. Zhang, Wang.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Guo, Q. Zhang, C. Zhang.
Obtained funding: Guo, Ren, Wang.
Administrative, technical, or material support: Guo, Q. Zhang, C. Zhang, Huang, Cao, Wang.
Supervision: Ren, Wang.
Conflict of Interest Disclosures: None reported.
Funding/Support: This study was funded by the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (Nos. 2021-1-I2M-047, 2020-I2M-2-015), National Natural Science Foundation (No. 81930063).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We acknowledge all patients who participated in this study and their families. We also would like to thank all staff of this follow-up study team at Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences for sample and clinical information collection.
SJL , Khan
K , Khoury
D . SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv
. Preprint posted online December 17, 2021. doi:10.1101/2021.12.08.21267417Google Scholar
D , Shamier
MC , Bogers
et al. SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Sci Immunol
. 2021;6(59):eabj1750. doi:10.1126/sciimmunol.abj1750Google ScholarCrossref